A putative SGLT-relevant mechanistic perspective on quercetin-3-O-glucoside and rutin in diabetic kidney disease. [PDF]
Harbuwono DS +11 more
europepmc +1 more source
SGLT2 inhibitors: mechanisms, physiology and pharmacology, and clinical applications. [PDF]
Zheng XT +9 more
europepmc +1 more source
Transcriptomics of S3 segment in mice: response to type 1 diabetes, SGLT1/2 inhibition, or GLP1 receptor agonism. [PDF]
Kim YC +5 more
europepmc +1 more source
Profiling the Expression of SGLT1 in Prostate Cancer
1 broadsideCurrent therapies of prostate cancer, the most frequently diagnosed cancer, are often ineffective and cause serious adverse effects.1 Upregulation of the epidermal growth factor receptor (EGFR), a receptor tyrosine kinase, has been linked ...
Blessing, Alicia
core
Sotagliflozin, a Dual SGLT1/2 Inhibitor, Modulates DNMT1 and Class I/II HDAC Expression in Association With Anticancer Effects in Breast and Lung Cancer Cells. [PDF]
Hima PK, Aswathy K, Duddukuri GR.
europepmc +1 more source
High-Glucose-Induced Metabolic and Epithelial Stress in Grass Carp Intestinal Epithelial Cells Associated with Methylation-Related Transcriptional Responses. [PDF]
Qian L +5 more
europepmc +1 more source
A single dose trial of mizagliflozin for the treatment of postbariatric hypoglycemia. [PDF]
Lawler HM +9 more
europepmc +1 more source
Dapagliflozin Beyond Glucose Lowering: Mechanisms of Renal and Systemic Protection. [PDF]
Wise ML, Alli AA.
europepmc +1 more source
The Nutraceutical Potential of Blackcurrant (<i>Ribes nigrum</i>) for Glycemic Control and Metabolic Health: Mechanistic and Translational Insights. [PDF]
Religa P +15 more
europepmc +1 more source
Cardioprotective Mechanisms of Sodium-Glucose Cotransporter-2 Inhibitors: What Have We Learned So Far? [PDF]
Qi L, Wright EM, Cai X.
europepmc +1 more source

